These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 24992976)

  • 1. [Importance of the tumor stem cell hypothesis for understanding ovarian cancer].
    Vochem R; Einenkel J; Horn LC; Ruschpler P
    Pathologe; 2014 Jul; 35(4):361-70. PubMed ID: 24992976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance.
    Ahmed N; Abubaker K; Findlay J; Quinn M
    J Cell Biochem; 2013 Jan; 114(1):21-34. PubMed ID: 22887554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD10
    Ffrench B; Gasch C; Hokamp K; Spillane C; Blackshields G; Mahgoub TM; Bates M; Kehoe L; Mooney A; Doyle R; Doyle B; O'Donnell D; Gleeson N; Hennessy BT; Stordal B; O'Riain C; Lambkin H; O'Toole S; O'Leary JJ; Gallagher MF
    Cell Death Dis; 2017 Oct; 8(10):e3128. PubMed ID: 29048400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of cancer stem cells in progressive growth and resistance of ovarian cancer: true or fiction?].
    Bar JK; Grelewski P; Lis-Nawara A; Drobnikowska K
    Postepy Hig Med Dosw (Online); 2015 Sep; 69():1077-86. PubMed ID: 26400893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enrichment for chemoresistant ovarian cancer stem cells from human cell lines.
    Cole JM; Joseph S; Sudhahar CG; Cowden Dahl KD
    J Vis Exp; 2014 Sep; (91):51891. PubMed ID: 25285606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer stem cells: opportunities and challenges.
    Chhabra R
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1889-97. PubMed ID: 25563493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer.
    Ge Y; Weygant N; Qu D; May R; Berry WL; Yao J; Chandrakesan P; Zheng W; Zhao L; Zhao KL; Drake M; Vega KJ; Bronze MS; Tomasek JJ; An G; Houchen CW
    Int J Cancer; 2018 Sep; 143(5):1162-1175. PubMed ID: 29577277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
    Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
    Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors.
    Hong IS; Lee HY; Nam JS
    Recent Pat Anticancer Drug Discov; 2015; 10(1):2-22. PubMed ID: 25479037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance.
    Mihanfar A; Aghazadeh Attari J; Mohebbi I; Majidinia M; Kaviani M; Yousefi M; Yousefi B
    J Cell Physiol; 2019 Apr; 234(4):3238-3253. PubMed ID: 30317560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian Cancer Stem Cells: Unraveling a Germline Connection.
    Parte SC; Smolenkov A; Batra SK; Ratajczak MZ; Kakar SS
    Stem Cells Dev; 2017 Dec; 26(24):1781-1803. PubMed ID: 29078734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Stem Cells and their Management in Cancer Therapy.
    Shenouda S; Kulkarni K; Abuetabh Y; Sergi C
    Recent Pat Anticancer Drug Discov; 2020; 15(3):212-227. PubMed ID: 32660407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTTG1: a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer.
    Parte S; Virant-Klun I; Patankar M; Batra SK; Straughn A; Kakar SS
    Stem Cell Rev Rep; 2019 Dec; 15(6):866-879. PubMed ID: 31482269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding and targeting cancer stem cells: therapeutic implications and challenges.
    Chen K; Huang YH; Chen JL
    Acta Pharmacol Sin; 2013 Jun; 34(6):732-40. PubMed ID: 23685952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian cancer stem cells: What progress have we made?
    Al-Alem LF; Pandya UM; Baker AT; Bellio C; Zarrella BD; Clark J; DiGloria CM; Rueda BR
    Int J Biochem Cell Biol; 2019 Feb; 107():92-103. PubMed ID: 30572025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can nanomedicines kill cancer stem cells?
    Zhao Y; Alakhova DY; Kabanov AV
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1763-83. PubMed ID: 24120657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.